Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LivaNova PLCLIVN · Entity 507 | Chief Innovation Officer | August 11, 2026 | August 13, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LivaNova PLC
Report date August 11, 2026 · Filed August 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 6,090 |
Ending reported balance
After 2026-08-11 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-08-11 · Exercise / conversion · Acquired 12,692 · Balance 18,782 Row 2 · 2026-08-11 · Disposition to issuer · Disposed 8,589 · Balance 10,193 F1: Shares withheld in payment of the base price in connection with the exercise of stock appreciation rights (SARs). Row 3 · 2026-08-11 · Tax withholding · Disposed 1,428 · Balance 8,765 F2: Shares withheld to satisfy tax liability. Row 4 · 2026-08-11 · Sale · Disposed 2,675 · Balance 6,090 F3: The shares were sold in multiple open-market transactions at prices from $77.6684 to $77.7900; the reported price reflects the weighted-average sale price. The reporting person undertakes to provide to LivaNova PLC (the Company), any security holder of the Company, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price. |
| Stock Appreciation RightsSEC Table II · derivative / convertible security · Conversion / exercise price $52.68 · Expires 2034-06-15 | Direct | 12,691 |
Reported balance
After 2026-08-11 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-08-11 · Exercise / conversion · Disposed 12,692 · Balance 12,691 F4: The SARs were granted on June 15, 2024, vesting in four equal annual installments beginning June 15, 2025, and are subject to forfeiture prior to vesting under the terms of the Amended and Restated LivaNova PLC 2022 Incentive Award Plan and the award agreement. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld in payment of the base price in connection with the exercise of stock appreciation rights (SARs).
F2: Shares withheld to satisfy tax liability.
F3: The shares were sold in multiple open-market transactions at prices from $77.6684 to $77.7900; the reported price reflects the weighted-average sale price. The reporting person undertakes to provide to LivaNova PLC (the Company), any security holder of the Company, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price.
F4: The SARs were granted on June 15, 2024, vesting in four equal annual installments beginning June 15, 2025, and are subject to forfeiture prior to vesting under the terms of the Amended and Restated LivaNova PLC 2022 Incentive Award Plan and the award agreement.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 11, 2026 Filed Aug 13, 2026 20:04 UTC | LivaNova PLC LIVN · Entity 507 | Exercise / conversionStock Appreciation Rights · Derivative | 12,692 | $0.00 Strike: $52.68 | $0.00 |
DisclosureSEC source: 0001639691-26-000094 · wk-form4_1786651446.xml · derivative · entry 5 Tezel Ahmet · CIK 0002023439 · Chief Innovation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,691 Underlying: Ordinary Shares · 12,692 shares Expires 2034-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The SARs were granted on June 15, 2024, vesting in four equal annual installments beginning June 15, 2025, and are subject to forfeiture prior to vesting under the terms of the Amended and Restated LivaNova PLC 2022 Incentive Award Plan and the award agreement. Read SEC document |
| August 11, 2026 Filed Aug 13, 2026 20:04 UTC | LivaNova PLC LIVN · Entity 507 | SaleOrdinary Shares | 2,675 | $77.74 | $207,942.46 |
DisclosureSEC source: 0001639691-26-000094 · wk-form4_1786651446.xml · nonDerivative · entry 4 Tezel Ahmet · CIK 0002023439 · Chief Innovation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,090 F3 · price: The shares were sold in multiple open-market transactions at prices from $77.6684 to $77.7900; the reported price reflects the weighted-average sale price. The reporting person undertakes to provide to LivaNova PLC (the Company), any security holder of the Company, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 11, 2026 Filed Aug 13, 2026 20:04 UTC | LivaNova PLC LIVN · Entity 507 | Tax withholdingOrdinary Shares | 1,428 | $77.86 | $111,184.08 |
DisclosureSEC source: 0001639691-26-000094 · wk-form4_1786651446.xml · nonDerivative · entry 3 Tezel Ahmet · CIK 0002023439 · Chief Innovation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,765 F2 · price: Shares withheld to satisfy tax liability. Read SEC document |
| August 11, 2026 Filed Aug 13, 2026 20:04 UTC | LivaNova PLC LIVN · Entity 507 | Disposition to issuerOrdinary Shares | 8,589 | $77.86 | $668,739.54 |
DisclosureSEC source: 0001639691-26-000094 · wk-form4_1786651446.xml · nonDerivative · entry 2 Tezel Ahmet · CIK 0002023439 · Chief Innovation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,193 F1 · price: Shares withheld in payment of the base price in connection with the exercise of stock appreciation rights (SARs). Read SEC document |
| August 11, 2026 Filed Aug 13, 2026 20:04 UTC | LivaNova PLC LIVN · Entity 507 | Exercise / conversionOrdinary Shares | 12,692 | $52.68 | $668,614.56 |
DisclosureSEC source: 0001639691-26-000094 · wk-form4_1786651446.xml · nonDerivative · entry 1 Tezel Ahmet · CIK 0002023439 · Chief Innovation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,782 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 20:09 UTC | LivaNova PLC LIVN · Entity 507 | Exercise / conversionRestricted Stock Units · Derivative | 2,965 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-26-000072 · wk-form4_1781726951.xml · derivative · entry 3 Tezel Ahmet · CIK 0002023439 · Chief Innovation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,931 Underlying: Ordinary Shares · 2,965 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Amended and Restated LivaNova PLC 2022 Incentive Award Plan (the Plan) and the award agreement. F4 · derivative.exercise_date: On June 15, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the second vesting having occurred on June 15, 2026. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement. F4 · derivative.expiration_date: On June 15, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the second vesting having occurred on June 15, 2026. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 20:09 UTC | LivaNova PLC LIVN · Entity 507 | Tax withholdingOrdinary Shares | 1,032 | $79.70 | $82,250.40 |
DisclosureSEC source: 0001639691-26-000072 · wk-form4_1781726951.xml · nonDerivative · entry 2 Tezel Ahmet · CIK 0002023439 · Chief Innovation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,090 F3 · shares: Shares withheld to satisfy tax liability. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 20:09 UTC | LivaNova PLC LIVN · Entity 507 | Exercise / conversionOrdinary Shares | 2,965 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-26-000072 · wk-form4_1781726951.xml · nonDerivative · entry 1 Tezel Ahmet · CIK 0002023439 · Chief Innovation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,122 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), 1.00 GBP par value. F2 · price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Amended and Restated LivaNova PLC 2022 Incentive Award Plan (the Plan) and the award agreement. Read SEC document |
| March 30, 2026 Filed Apr 1, 2026 21:20 UTC | LivaNova PLC LIVN · Entity 507 | GrantPerformance Stock Units · Derivative | 4,624 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-26-000027 · wk-form4_1775078427.xml · derivative · entry 7 Tezel Ahmet · CIK 0002023439 · Chief Innovation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,624 Underlying: Ordinary Shares · 4,624 shares Expires not disclosed F6 · derivative.exercise_price: Each performance stock unit (PSU) represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the applicable Company incentive award plan identified in the footnote for such grant and the award agreement. F9 · derivative.exercise_date: On March 30, 2026, reporting person was granted PSUs to vest or lapse on March 30, 2029 based on how the Company's adjusted earnings per share (EPS) for the performance period 2026-2028 compares to a target determined by the Second A&R 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. F9 · derivative.expiration_date: On March 30, 2026, reporting person was granted PSUs to vest or lapse on March 30, 2029 based on how the Company's adjusted earnings per share (EPS) for the performance period 2026-2028 compares to a target determined by the Second A&R 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. Read SEC document |
| March 30, 2026 Filed Apr 1, 2026 21:20 UTC | LivaNova PLC LIVN · Entity 507 | GrantPerformance Stock Units · Derivative | 4,624 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-26-000027 · wk-form4_1775078427.xml · derivative · entry 6 Tezel Ahmet · CIK 0002023439 · Chief Innovation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,624 Underlying: Ordinary Shares · 4,624 shares Expires not disclosed F6 · derivative.exercise_price: Each performance stock unit (PSU) represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the applicable Company incentive award plan identified in the footnote for such grant and the award agreement. F8 · derivative.exercise_date: On March 30, 2026, reporting person was granted PSUs to vest or lapse on March 30, 2029 based on the Company's relative total shareholder return (rTSR) for the three-year period beginning on January 1, 2026 and ending December 31, 2028 relative to the total shareholder return of an index of companies, as determined by the Second A&R 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. F8 · derivative.expiration_date: On March 30, 2026, reporting person was granted PSUs to vest or lapse on March 30, 2029 based on the Company's relative total shareholder return (rTSR) for the three-year period beginning on January 1, 2026 and ending December 31, 2028 relative to the total shareholder return of an index of companies, as determined by the Second A&R 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. Read SEC document |
| March 30, 2026 Filed Apr 1, 2026 21:20 UTC | LivaNova PLC LIVN · Entity 507 | GrantPerformance Stock Units · Derivative | 4,624 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-26-000027 · wk-form4_1775078427.xml · derivative · entry 5 Tezel Ahmet · CIK 0002023439 · Chief Innovation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,624 Underlying: Ordinary Shares · 4,624 shares Expires not disclosed F6 · derivative.exercise_price: Each performance stock unit (PSU) represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the applicable Company incentive award plan identified in the footnote for such grant and the award agreement. F7 · derivative.exercise_date: On March 30, 2026, reporting person was granted PSUs to vest or lapse on March 30, 2029 based on how the Company's revenue growth for the performance period 2026-2028 compares to a target determined by the Second A&R 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. F7 · derivative.expiration_date: On March 30, 2026, reporting person was granted PSUs to vest or lapse on March 30, 2029 based on how the Company's revenue growth for the performance period 2026-2028 compares to a target determined by the Second A&R 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. Read SEC document |
| March 30, 2026 Filed Apr 1, 2026 21:20 UTC | LivaNova PLC LIVN · Entity 507 | GrantRestricted Stock Units · Derivative | 13,873 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-26-000027 · wk-form4_1775078427.xml · derivative · entry 4 Tezel Ahmet · CIK 0002023439 · Chief Innovation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,873 Underlying: Ordinary Shares · 13,873 shares Expires not disclosed F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the applicable Company incentive award plan identified in the footnote for such grant and the award agreement. F5 · derivative.exercise_date: On March 30, 2026, reporting person was granted RSUs subject to a three-year vesting in equal annual installments, the first vesting occurring on March 30, 2027. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Second Amended and Restated LivaNova PLC 2022 Incentive Award Plan (the Second A&R 2022 Plan) and the award agreement. F5 · derivative.expiration_date: On March 30, 2026, reporting person was granted RSUs subject to a three-year vesting in equal annual installments, the first vesting occurring on March 30, 2027. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Second Amended and Restated LivaNova PLC 2022 Incentive Award Plan (the Second A&R 2022 Plan) and the award agreement. Read SEC document |
| March 30, 2026 Filed Apr 1, 2026 21:20 UTC | LivaNova PLC LIVN · Entity 507 | Exercise / conversionRestricted Stock Units · Derivative | 3,408 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-26-000027 · wk-form4_1775078427.xml · derivative · entry 3 Tezel Ahmet · CIK 0002023439 · Chief Innovation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,814 Underlying: Ordinary Shares · 3,408 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the applicable Company incentive award plan identified in the footnote for such grant and the award agreement. F4 · derivative.exercise_date: On March 30, 2025, reporting person was granted RSUs subject to a three-year vesting in equal annual installments, the first vesting occurring on March 30, 2026. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the First Amended and Restated LivaNova PLC 2022 Incentive Award Plan (the First A&R 2022 Plan) and the award agreement. F4 · derivative.expiration_date: On March 30, 2025, reporting person was granted RSUs subject to a three-year vesting in equal annual installments, the first vesting occurring on March 30, 2026. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the First Amended and Restated LivaNova PLC 2022 Incentive Award Plan (the First A&R 2022 Plan) and the award agreement. Read SEC document |
| March 30, 2026 Filed Apr 1, 2026 21:20 UTC | LivaNova PLC LIVN · Entity 507 | Tax withholdingOrdinary Shares | 1,186 | $61.27 | $72,666.22 |
DisclosureSEC source: 0001639691-26-000027 · wk-form4_1775078427.xml · nonDerivative · entry 2 Tezel Ahmet · CIK 0002023439 · Chief Innovation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,157 F2 · shares: Shares withheld to satisfy tax liability. Read SEC document |
| March 30, 2026 Filed Apr 1, 2026 21:20 UTC | LivaNova PLC LIVN · Entity 507 | Exercise / conversionOrdinary Shares | 3,408 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-26-000027 · wk-form4_1775078427.xml · nonDerivative · entry 1 Tezel Ahmet · CIK 0002023439 · Chief Innovation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,343 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), GBP 1.00 par value. Read SEC document |
| June 15, 2025 Filed Jun 17, 2025 20:53 UTC | LivaNova PLC LIVN · Entity 507 | Exercise / conversionRestricted Stock Units · Derivative | 2,967 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-25-000076 · wk-form4_1750193624.xml · derivative · entry 3 Tezel Ahmet · CIK 0002023439 · Chief Innovation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,896 Underlying: Ordinary Shares · 2,967 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2022 Incentive Award Plan (the Plan) and the award agreement. F4 · derivative.exercise_date: On June 15, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on June 15, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement. F4 · derivative.expiration_date: On June 15, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on June 15, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement. Read SEC document |
| June 15, 2025 Filed Jun 17, 2025 20:53 UTC | LivaNova PLC LIVN · Entity 507 | Tax withholdingOrdinary Shares | 1,032 | $45.76 | $47,224.32 |
DisclosureSEC source: 0001639691-25-000076 · wk-form4_1750193624.xml · nonDerivative · entry 2 Tezel Ahmet · CIK 0002023439 · Chief Innovation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,935 F3 · shares: Shares withheld to satisfy tax liability. Read SEC document |
| June 15, 2025 Filed Jun 17, 2025 20:53 UTC | LivaNova PLC LIVN · Entity 507 | Exercise / conversionOrdinary Shares | 2,967 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-25-000076 · wk-form4_1750193624.xml · nonDerivative · entry 1 Tezel Ahmet · CIK 0002023439 · Chief Innovation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,967 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), 1.00 GBP par value. F2 · price: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2022 Incentive Award Plan (the Plan) and the award agreement. Read SEC document |
| March 30, 2025 Filed Apr 2, 2025 01:01 UTC | LivaNova PLC LIVN · Entity 507 | GrantStock Appreciation Rights · Derivative | 22,378 | $0.00 Strike: $39.13 | $0.00 |
DisclosureSEC source: 0001639691-25-000030 · wk-form4_1743555691.xml · derivative · entry 5 Tezel Ahmet · CIK 0002023439 · Chief Innovation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,378 Underlying: Ordinary Shares · 22,378 shares Expires 2035-03-30 F7 · derivative.exercise_date: On March 30, 2025, reporting person was granted stock appreciation rights (SARs) subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2026. The SARs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement. Read SEC document |
| March 30, 2025 Filed Apr 2, 2025 01:01 UTC | LivaNova PLC LIVN · Entity 507 | GrantPerformance Stock Units · Derivative | 10,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-25-000030 · wk-form4_1743555691.xml · derivative · entry 4 Tezel Ahmet · CIK 0002023439 · Chief Innovation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,222 Underlying: Ordinary Shares · 10,222 shares Expires not disclosed F3 · derivative.exercise_price: Each performance stock unit (PSU) represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Plan and the award agreement. F6 · derivative.exercise_date: On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on the Company's total shareholder return (TSR) for the three-year period beginning on January 1, 2025 and ending December 31, 2027 relative to the TSR of an index of companies, as determined by the Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. F6 · derivative.expiration_date: On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on the Company's total shareholder return (TSR) for the three-year period beginning on January 1, 2025 and ending December 31, 2027 relative to the TSR of an index of companies, as determined by the Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. Read SEC document |
| March 30, 2025 Filed Apr 2, 2025 01:01 UTC | LivaNova PLC LIVN · Entity 507 | GrantPerformance Stock Units · Derivative | 5,111 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-25-000030 · wk-form4_1743555691.xml · derivative · entry 3 Tezel Ahmet · CIK 0002023439 · Chief Innovation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,111 Underlying: Ordinary Shares · 5,111 shares Expires not disclosed F3 · derivative.exercise_price: Each performance stock unit (PSU) represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Plan and the award agreement. F5 · derivative.exercise_date: On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on how the Company's Return on Investment Capital (ROIC) calculated for the performance period 2025-2027 compares to a target determined by the Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. F5 · derivative.expiration_date: On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on how the Company's Return on Investment Capital (ROIC) calculated for the performance period 2025-2027 compares to a target determined by the Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. Read SEC document |
| March 30, 2025 Filed Apr 2, 2025 01:01 UTC | LivaNova PLC LIVN · Entity 507 | GrantPerformance Stock Units · Derivative | 5,111 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-25-000030 · wk-form4_1743555691.xml · derivative · entry 2 Tezel Ahmet · CIK 0002023439 · Chief Innovation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,111 Underlying: Ordinary Shares · 5,111 shares Expires not disclosed F3 · derivative.exercise_price: Each performance stock unit (PSU) represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Plan and the award agreement. F4 · derivative.exercise_date: On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on how the Company's free cash flow (FCF) for performance period 2025-2027 compares to a target determined by the Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. F4 · derivative.expiration_date: On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on how the Company's free cash flow (FCF) for performance period 2025-2027 compares to a target determined by the Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. Read SEC document |
| March 30, 2025 Filed Apr 2, 2025 01:01 UTC | LivaNova PLC LIVN · Entity 507 | GrantRestricted Stock Units · Derivative | 10,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-25-000030 · wk-form4_1743555691.xml · derivative · entry 1 Tezel Ahmet · CIK 0002023439 · Chief Innovation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,222 Underlying: Ordinary Shares · 10,222 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2022 Incentive Award Plan (the Plan) and the award agreement. F2 · derivative.exercise_date: On March 30, 2025, reporting person was granted RSUs subject to a three-year vesting in equal annual installments, the first vesting occurring on March 30, 2026. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement. F2 · derivative.expiration_date: On March 30, 2025, reporting person was granted RSUs subject to a three-year vesting in equal annual installments, the first vesting occurring on March 30, 2026. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement. Read SEC document |
| June 15, 2024 Filed Jun 18, 2024 20:06 UTC | LivaNova PLC LIVN · Entity 507 | GrantStock Appreciation Rights · Derivative | 25,383 | $0.00 Strike: $52.68 | $0.00 |
DisclosureSEC source: 0001639691-24-000098 · wk-form4_1718741187.xml · derivative · entry 5 Tezel Ahmet · CIK 0002023439 · Chief Innovation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,383 Underlying: Ordinary Shares · 25,383 shares Expires 2034-06-15 F7 · derivative.exercise_date: On June 15, 2024, reporting person was granted stock appreciation rights ("SARs") subject to a four-year vesting in equal annual installments, the first vesting occurring on June 15, 2025. The SARs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement. Read SEC document |
| June 15, 2024 Filed Jun 18, 2024 20:06 UTC | LivaNova PLC LIVN · Entity 507 | GrantPerformance Stock Units · Derivative | 7,118 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000098 · wk-form4_1718741187.xml · derivative · entry 4 Tezel Ahmet · CIK 0002023439 · Chief Innovation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,118 Underlying: Ordinary Shares · 7,118 shares Expires not disclosed F3 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Plan and the award agreement. F6 · derivative.exercise_date: On June 15, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on the Company's total shareholder return ("TSR") for the three-year period beginning on January 1, 2024 and ending December 31, 2026 relative to the TSR of an index of companies, as determined by the Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. F6 · derivative.expiration_date: On June 15, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on the Company's total shareholder return ("TSR") for the three-year period beginning on January 1, 2024 and ending December 31, 2026 relative to the TSR of an index of companies, as determined by the Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. Read SEC document |
| June 15, 2024 Filed Jun 18, 2024 20:06 UTC | LivaNova PLC LIVN · Entity 507 | GrantPerformance Stock Units · Derivative | 3,559 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000098 · wk-form4_1718741187.xml · derivative · entry 3 Tezel Ahmet · CIK 0002023439 · Chief Innovation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,559 Underlying: Ordinary Shares · 3,559 shares Expires not disclosed F3 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Plan and the award agreement. F5 · derivative.exercise_date: On June 15, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's Return on Investment Capital ("ROIC") calculated for the performance period 2024-2026 compares to a target determined by the Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. F5 · derivative.expiration_date: On June 15, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's Return on Investment Capital ("ROIC") calculated for the performance period 2024-2026 compares to a target determined by the Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. Read SEC document |
| June 15, 2024 Filed Jun 18, 2024 20:06 UTC | LivaNova PLC LIVN · Entity 507 | GrantPerformance Stock Units · Derivative | 3,559 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000098 · wk-form4_1718741187.xml · derivative · entry 2 Tezel Ahmet · CIK 0002023439 · Chief Innovation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,559 Underlying: Ordinary Shares · 3,559 shares Expires not disclosed F3 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Plan and the award agreement. F4 · derivative.exercise_date: On June 15, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's free cash flow ("FCF") for performance period 2024-2026 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. F4 · derivative.expiration_date: On June 15, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's free cash flow ("FCF") for performance period 2024-2026 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement. Read SEC document |
| June 15, 2024 Filed Jun 18, 2024 20:06 UTC | LivaNova PLC LIVN · Entity 507 | GrantRestricted Stock Units · Derivative | 11,863 | $0.00 | $0.00 |
DisclosureSEC source: 0001639691-24-000098 · wk-form4_1718741187.xml · derivative · entry 1 Tezel Ahmet · CIK 0002023439 · Chief Innovation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,863 Underlying: Ordinary Shares · 11,863 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of LivaNova PLC ("the Company") GBP 1.00 par value in accordance with the terms of the Company's 2022 Incentive Award Plan ("the Plan") and the award agreement. F2 · derivative.exercise_date: On June 15, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting occurring on June 15, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement. F2 · derivative.expiration_date: On June 15, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting occurring on June 15, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.